Article Information
History
- December 5, 2022.
Article Versions
- Version 1 (December 1, 2022 - 15:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Zhidong Zhang1,†,
- Xuenan Pi1,†,
- Chang Gao1,
- Jun Zhang2,
- Lin Xia1,
- Xiaoqin Yan2,
- Xinlei Hu1,
- Ziyue Yan2,
- Shuxin Zhang3,
- Ailin Wei7,
- Yuer Guo1,
- Jingfeng Liu5,
- Ang Li4,
- Xiaolong Liu5,
- Wei Zhang6,
- Yanhui Liu3 and
- Dan Xie1,*
- 1National Frontier Center of Disease Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, P. R. China
- 2Tailai Inc., Shanghai 200233, P. R. China
- 3Department of Neurosurgery, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, P. R. China
- 4Department of Pancreatic Surgery, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, P. R. China
- 5Mengchao Hepatobiliary Hospital of Fujian Medical University, Xihong Road 312, Fuzhou 350025, Fujian Province, P. R. China
- 6Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of the Second Military Medical University, Shanghai 200433, Shanghai, P. R. China
- 7Guang’an People’s Hospital, Guang’an, China
- ↵*Correspondence to: Dr Dan Xie, National Frontier Center of Disease Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, P. R. China. Tel: +86-28-8558-2944; Fax: +86-28-8558-2944; E-mail: danxie{at}scu.edu.cn (D. Xie).
↵† These authors contributed equally to this work as joint first authors.
Posted December 05, 2022.
Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA
